Palmitoylation is a critical post-translational modification that anchors proteins to, and regulates transport across, the lipid bilayer. Palmitoylation enzymes have been assumed to select their substrates based on a protein's primary sequence, but a consensus sequence has been slow to emerge. A study of the sodium/calcium exchanger now suggests that secondary structure may hold the key to understanding the determinants of this modification.
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Palmitoylation is the reversible post-translational covalent addition of C16 fatty acids to protein cysteines via S-acylation. This modification controls the protein's trafficking and association with membranes and shapes cellular signaling (1) . Specifically, palmitoylation of many membrane proteins regulates ion, hormone, and metabolite transport across the membrane. Given these regulatory functions, understanding the mechanisms of palmitoylation is also central to a full understanding of signaling pathways. The DHHC acyltransferase enzymes that introduce palmitoyl groups have been assumed to operate like other modifying enzymes such as kinases, where determining a consensus motif in the primary sequence can be used to identify the enzyme's substrate pool. However, the evidence for this assumption is limited: A clear consensus motif for palmitoylation has not emerged, and structural information that could guide further studies is inadequate. A new study by Fuller and colleagues (2) provides a possible explanation for this conundrum in their discovery that a secondary structure is needed for palmitoylation of the sodium/calcium exchanger 1 (NCX1). 2 In mammals, there are three gene isoforms of NCX (NCX1-3), with their splice variants being expressed in a tissue-specific manner to maintain ion homeostasis (3) . NCX proteins include 10 transmembrane helices (TM1-TM10) (4), with an extended cytoplasmic f-loop between TM5 and TM6 containing two Ca 2ϩ -binding regulatory domains (CBD1 and CBD2) connected through a very short interdomain linker ( Fig. 1) (5) . This segment between the CBD2 and TM6 has been designated as a putative ␣-catenin-like domain, although its structure and function remain uncharacterized (5) . Crystal structures of mammalian CBDs and mutational studies (6 -8) revealed that Ca 2ϩ binding to CBD1 activates NCX, whereas Ca 2ϩ interaction with CBD2 alleviates the Na ϩ -induced inactivation (6, 7) . Alternative splicing (exclusively allocated at CBD2) provides further evidence that this region modulates the Ca 2ϩ -binding affinityandcapacityatbothCBDsandthusdiversifiestheCa 2ϩ -dependent activation through CBD1 and Ca 2ϩ -dependent alleviation of Na ϩ -induced inactivation through CBD2 (7-9). Fuller and collaborators (2) previously found that palmitoylation of the f-loop controls NCX inactivation and internalization during stress signaling. In the present study, Fuller and collaborators (2) have identified a short ␣-helix (residues 740 -756) downstream of the single palmitoylation site (Cys-739 of NCX1; located at the C-terminal end of the CBD2 domain just prior to TM6) as governing S-acylation. Fuller and colleagues (2) began their study by searching for local primary sequence elements that alter palmitoylation propensity. However, the nearby mutations tested had little effect on lipidation. Instead, the authors found that residues 740 -756 were necessary and sufficient for palmitoylation. This sequence is also predicted to be an ␣-helix structure; further constructs showed that mutational interruptions in ␣-helical folding decreased or aborted palmitoylation without affecting protein trafficking. The ␣-helix is identical in NCX2 and NCX3, leading to an exciting working hypothesis in which the hydrophobic face of the ␣-helix represents a common structural template to direct the interaction of the NCX palmitoylation site with the S-acylation enzyme. It is worth noting that the NCX2 and NCX3 isoforms contain cysteines at the N-and C-terminal ends of the helix (analogous to positions 739 and 757 in NCX1); the authors propose that these two cysteines could be selectively targeted for palmitoylation in distinct NCX variants (Fig. 1) .
Another fascinating finding by Fuller and collaborators (2) is that when the ␣-helix is incorporated next to cysteines that are not normally modified, in both an altered version of NCX1 and a YFP variant, the flanking cysteines now become palmitoylated. These results underscore the fundamental role of the ␣-helix in mediating recognition with one or more S-acylation enzymes and suggest that the principles of a "consensus sequence" may be largely inapplicable for recognizing the palmitoylation site in NCX (and perhaps in many other proteins as well). Indeed, other data in the paper from Fuller and colleagues (2) suggest that there are additional elements that influence palmitoylation: The first two turns of the ␣-helix are essential for recognition in both full-length and truncated NCX1 constructs, but the lack of the next two turns can be somehow mitigated by transmembrane domains in the full-
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length protein that likely help to position Cys-739 near the membrane. It will be exciting to identify the exact structural elements determining the interaction of the ␣-helix domain with the active site of S-acylation enzymes by applying advanced approaches of structural biology and biophysics. The artificial incorporation of this ␣-helix sequence near cysteines that are not normally palmitoylated (2) may provide a practical and versatile tool for controlling structural stability of predefined membrane proteins in distinct cell types. Additionally, targeted insertion of palmitoylation sites could enable many biotechnological applications, as well as allow the testing of long-standing but technically intractable hypotheses. For example, structurally predefined insertions of palmitoylation sites can be used for segregating substrate selectivity among distinct enzymes involved in reversible palmitoylation as well as for distinguishing their specific roles in trafficking and cellular signaling. To me, perhaps the most exciting part of the present work by Fuller and collaborators (2) is an interesting clue for a possible contribution of the ␣-helix in shaping the propagation of the allosteric signal from the CBDs to the ion-transport domains (9) . Because the palmitoylation site of NCX sits between CBD2 and TM6, it is possible that the conformational stability of this segment (perhaps controlled by palmitoylation) could play a role in conducting and modulating the allosteric signal. In collaboration with other laboratories we have shown that Ca 2ϩ binding to CBD1 rigidifies the C-terminal tip of CBD1 and then the C-terminal tip of CBD2 through the formation of a hydrogen-bonded salt-bridge network at the twodomain interface (8) , where the strength and span of rigidification is splice-dependent (10) . It will be fascinating to see whether the palmitoylation domain affects backbone dynamics to confer functional changes to the protein as a whole. The new work from Fuller and colleagues (2) thus sets the stage for elucidating how palmitoylation affects the conformational dynamics and regulatory specificity of NCXs and of many other proteins as well. The challenge is to resolve how the allosteric signal propagates from CBD1 to transport sites and how this signal is modulated by splice segment. Recent structure-dynamic studies (9) revealed that Ca 2ϩ binding to CBD1 rigidifies the backbone dynamics from the C-terminal tip of CBD1 to the C-terminal tip of CBD2 (solid red arrow), where there is no evidence for allosteric signal propagation through the alternative pathway (dotted red arrow). The ␣-helix discovered by Fuller and collaborators (2) is located between CBD2 and TM6 and plays a critical role in mediating the palmitoylation of Cys-739. How the palmitoylation of Cys-739 in NCX1 (or other NCX variants) influences function, such as affecting the propagation of the allosteric signal toward the ion-binding/transport domains, remains to be discovered.
